Table 2

Prevalence of comorbidities by BMI and diabetes status

UnderweightNormal BMIOverweightObese grade 1Obese grade 2Obese grade 3p Value
Patients with diabetes (n=8046)
 CAD, n (%)41 (18.1)417 (24.6)689 (32.2)588 (30.9)308 (27.9)208 (21.2)<0.0001
 Hypertension, n (%)95 (41.9)866 (51.0)1147 (53.7)1116 (58.7)641 (58.0)592 (60.4)<0.0001
 CKD, n (%)61 (26.9)428 (25.2)589 (27.6)483 (25.4)275 (24.9)201 (20.5)0.0028
 COPD, n (%)39 (17.2)250 (14.7)235 (11.0)258 (13.6)122 (11.0)123 (12.6)0.0013
 Malignancy, n (%)33 (14.5)221 (13.0)247 (11.6)158 (8.3)82 (7.4)45 (4.6)<0.0001
 Hyperlipidemia, n (%)59 (26.0)662 (39.0)1065 (49.8)959 (50.5)547 (49.5)389 (39.7)<0.0001
Patients without diabetes (n=21 577)
 CAD, n (%)123 (12.2)1088 (15.4)1261 (18.5)615 (16.3)254 (15.6)145 (11.2)<0.0001
 Hypertension, n (%)362 (35.9)2682 (38.0)3254 (47.7)1927 (51.2)902 (55.4)705 (54.4)<0.0001
 CKD, n (%)111 (11.0)749 (10.6)641 (9.4)379 (10.1)154 (9.5)135 (10.4)0.18
 COPD, n (%)211 (20.9)817 (11.6)604 (8.9)314 (8.3)108 (6.6)111 (8.6)<0.0001
 Malignancy, n (%)186 (18.5)1026 (14.5)863 (12.6)407 (10.8)119 (7.3)78 (6.0)<0.0001
 Hyperlipidemia, n (%)166 (16.5)1671 (23.7)2149 (31.5)1203 (32.0)514 (31.6)324 (25.0)<0.0001
  • BMI, body mass index; CAD, coronary artery disease; CKD, chronic kidney disease; COPD, chronic obstructive pulmonary disease.